IHI — iShares U.S. Medical Devices ETF
Data updated: 2026-08-24
IHI — iShares U.S. Medical Devices ETF. United States Large Cap Blend / Core Health Care Equity · $3.02B AUM. Holdings, fees, performance and SEC filings.
IHI Fund Overview
IHI — iShares U.S. Medical Devices ETF is a US ETF managed by iSHARES TRUST, categorised as United States Large Cap Blend / Core Health Care Equity. ABC INVEST provides holdings, performance, costs, cashflows, risk data, prospectus documents and SEC filings, sourced from SEC filings.
- Type: US ETF
- Manager: iSHARES TRUST
- Category: United States Large Cap Blend / Core Health Care Equity
- Assets under management: $3.02B
- 1-year return: -20.8%
- Ticker: IHI
- SEC CIK: 0001100663
- SEC series ID: S000009419
- Share class ID: C000025773
IHI Holdings
Top 10 holdings of iShares U.S. Medical Devices ETF by percentage of net assets, from the fund's latest SEC N-PORT filing.
| Holding | % of net assets |
|---|---|
| Abbott Laboratories | 16.93% |
| Intuitive Surgical, Inc. | 15.09% |
| Stryker Corporation | 11.64% |
| Edwards Lifesciences Corporation | 4.75% |
| Becton, Dickinson And Company | 4.63% |
| Ge Healthcare Technologies Inc. | 4.51% |
| Medtronic Public Limited Company | 4.40% |
| Resmed Inc. | 4.38% |
| Idexx Laboratories, Inc. | 4.27% |
| Dexcom, Inc. | 4.02% |
IHI Portfolio Allocation
Asset-class allocation of iShares U.S. Medical Devices ETF by percentage of net assets, from the latest SEC N-PORT filing.
| Asset class | Allocation |
|---|---|
| Equity | 99.8% |
| Cash & Equivalents | 2.3% |
IHI Performance
Total returns for IHI (as of 2026-09-01), from SEC filings.
| Period | Total return |
|---|---|
| YTD | -20.3% |
| 1 year | -20.8% |
| 3 years (annualised) | -3.9% |
| 5 years (annualised) | -3.4% |
IHI Risk Information
Risk metrics for IHI, derived from monthly returns in SEC filings.
- 1-year volatility (annualised): 16.4%
IHI Costs and Fees
IHI costs about $38 per $10,000 invested per year in fund expenses.
- Net expense ratio: 0.38%
- Gross expense ratio: 0.38%
- Portfolio turnover: 16%
- Brokerage commissions: 0.16 bps of average net assets (SEC N-CEN)
IHI Cashflows
Over the 12 months to 2026-06, iShares U.S. Medical Devices ETF had net outflows of $767.84M, from monthly SEC N-PORT filings.
| Month | Net flow |
|---|---|
| 2026-06 | $8.42M |
| 2026-05 | −$73.39M |
| 2026-04 | $161.29M |
| 2026-03 | −$42.15M |
| 2026-02 | −$98.19M |
| 2026-01 | −$194.11M |
IHI Debt Constituents
No individual debt constituents are reported in iShares U.S. Medical Devices ETF's latest SEC N-PORT filing.
IHI Prospectus and SEC Filings
Official iShares U.S. Medical Devices ETF filings on SEC EDGAR — prospectus, portfolio holdings and annual reports.
- Prospectus (485BPOS) — filed 2025-07-22
- Prospectus (485BPOS) — filed 2024-07-19
- Prospectus (485BPOS) — filed 2023-07-20
- Portfolio holdings (N-PORT) — filed 2026-08-24
- Portfolio holdings (N-PORT) — filed 2026-05-22
- Portfolio holdings (N-PORT) — filed 2026-02-23
- Annual census (N-CEN) — filed 2026-06-15
- Annual census (N-CEN) — filed 2025-06-13
Related Funds
Other United States Large Cap Blend / Core Health Care Equity funds tracked on ABC INVEST:
Data Sources
ABC INVEST compiles this page from public filings made to the U.S. Securities and Exchange Commission (SEC) through EDGAR: portfolio holdings and monthly cashflows from Form N-PORT, expenses and returns from fund prospectuses (Form 485BPOS) and the SEC DERA Risk/Return Summary data sets, annual data from Form N-CEN, and shareholder reports from Form N-CSR.